© 2020 MJH Life Sciences and HCPLive. All rights reserved.
© 2020 MJH Life Sciences™ and HCPLive. All rights reserved.
November 10, 2020
Favorable phase 2 results with the TYK2 inhibitor for psoriatic arthritis at ACR 2020 coincided with announced positive phase 3 trial results for psoriasis.
November 09, 2020
A secukinumab researcher explains why the practice may become the "next stethoscope" of medicine.
New findings show a unique series of markers could indicate particular black SLE patient risks.
November 07, 2020
A real-world study shows the therapy was slightly more efficacious for biologic-naive PsA patients.
A systematic review suggests patients taking immunosuppressive therapy may not be at as heightened risk of infection as previously thought.
An interview with a study author on the promising findings, and the use of ultrasonography in assessing psoriatic arthritis treatment.
Children hospitalized from the condition face a 14-fold increased risk of MACE.
November 06, 2020
The world is suddenly fixed on the field's most promising agents for an unprecedented virus. It's created a unique situation for specialists to collaborate.
The common rheumatic drug was found in a cohort analysis to be linked to greater regional TB outbreaks.
Less than 2% of surveyed families with rheumatic-disease children had reported a COVID-19 case in the early pandemic—and even fewer had physician-confirmed symptoms.